红细胞衍生的外体瘤性微RNA促进癌症的发展和进展
medRxiv : the preprint server for health sciences
|May 20, 2024
概括
红细胞通过外体转移促进癌症的miR-93-5p到肺癌细胞,加速瘤生长. 准这种微RNA为肺癌提供了新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 红细胞 (RBC) 在癌症发展中的作用基本上是未知的.
- 红细胞中的异常微RNA (miRNA) 与肺癌有关,其中miR-93-5p被确定为关键参与者.
研究的目的:
- 为了研究红细胞衍生的miR-93-5p在肺癌进展中的作用.
- 确定miR-93-5p从红细胞转移到癌细胞的机制.
- 评估向红细胞衍生的miR-93-5p.p.的治疗潜力.
主要方法:
- 从肺癌患者的红细胞衍生外体中量化miR-93-5p.
- 评估miR-93-5p水平与患者存活率之间的关联.
- 在体外研究miR-93-5p对癌细胞的外体转移及其对PTEN的影响.
- 在体内异种移植模型评估红细胞衍生的miR-93-5p对瘤生长的影响.
主要成果:
- 在肺癌患者的红细胞衍生外体中发现了升高的miR-93-5p水平,与较短的生存时间相关.
- 红细胞衍生的miR-93-5p通过外体转移到癌细胞,准PTEN并增强扩散,入侵和迁移.
- 在体内给予红细胞衍生的miR-93-5p加速了瘤的生长.
- 在异种移植模型中,抑制miR-93-5p减少了瘤生长.
结论:
- 红细胞通过通过外体细胞转移致癌性miR-93-5p,积极促进肺癌的进展.
- 这一发现为肺癌提供了基于外体的新型诊断和治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


